弘森药业 (873735.oc)

+ 收藏

财务分析(报告期)(弘森药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2022年年报2022年三季报2022年中报
主要指标:
 营业收入(元) 403,208,708.49290,450,086.53225,827,272.71361,004,989.31268,702,837.84184,639,463.19
 营业利润(元) 106,849,612.7880,456,248.7070,866,939.35106,916,846.9677,502,970.7944,482,951.37
 利润总额(元) 105,344,021.2479,761,140.2470,170,231.87106,740,484.1077,667,477.6044,647,458.18
 净利润(元) 93,710,108.5670,400,444.2561,397,069.0594,631,498.2967,111,323.2837,883,668.57
 归属于母公司股东的净利润(元) 93,710,108.5670,400,444.2561,397,069.0594,631,498.2967,111,323.2837,883,668.57
盈利能力:
 销售毛利率(%) 57.2158.3861.5363.9565.6265.64
 销售净利率(%) 23.2424.2428.8325.8424.9624.32
 净资产收益率(%) 45.8539.2632.26---
 总资产报酬率ROA(%) 31.0326.1122.62---
 投入资本回报率ROIC(%) 42.4632.9230.7849.4436.7924.40
营运能力:
 存货周转率(次) 3.112.291.61---
 应收账款周转率(次) 129.1844.9740.31---
 总资产周转率(次) 1.190.950.73---
偿债能力:
 资产负债率(%) 32.8833.2535.8546.7149.1940.87
 股东权益比率(%) 67.1266.7564.1553.2950.8159.13
 已获利息倍数(倍) -2,956.24-445.77-219.39306.73401.36240.01
 流动比率 1.421.191.050.930.801.05
 速动比率 0.710.460.410.480.370.48
发展能力:
 营业收入增长率(%) 11.698.0923.9724.3427.9026.88
 营业利润增长率(%) 1.704.6448.9188.3772.3675.54
 税后利润增长率(%) 0.454.9647.0186.9957.7380.60
 净资产增长率(%) 27.4434.045.6923.85--
 总资产增长率(%) 1.001.950.1620.31--

前瞻产业研究院